Showing results (191-200 of 207) with videos related to
Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|January 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trialYuejun Liu, Ying Chen, Jianhua Ma, et al.Burns & Trauma|July 21, 2020
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)Aiping Wang, Guozhong Lv, Xingbo Cheng, et al.Diabetes/Metabolism Research and Reviews|March 26, 2019
Standards of medical care for type 2 diabetes in China 2019Weiping Jia, Jianping Weng, Dalong Zhu, et al.Journal of Diabetes|October 7, 2021
Pregnancy outcomes in women with type 1 diabetes in China during 2004 to 2014: A retrospective study (the CARNATION Study)Sihui Luo, Xingwu Ran, Mei Zhang, et al.Diabetes, Obesity & Metabolism|December 12, 2017
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trialLinong Ji, Jing Liu, Jing Yang, et al.Diabetes, Obesity & Metabolism|November 25, 2018
Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide surveyYufei Xiang, Gan Huang, Yaxi Zhu, et al.The Lancet. Diabetes & Endocrinology|May 9, 2018
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 studyDalong Zhu, Shenglian Gan, Yu Liu, et al.Diabetes/Metabolism Research and Reviews|March 19, 2019
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)Yuqian Bao, Li Chen, Liming Chen, et al.Diabetes Research and Clinical Practice|February 4, 2023
Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitusJian Zhu, Junfeng Han, Liehua Liu, et al.Nature Communications|January 7, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.Pageof 21